Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Three-Arm Randomized Trial to Compare Adjuvant Adriamycin and Cyclophosphamide Followed by Taxotere (AC-T); Adriamycin and Taxotere (AT); and Adriamycin, Taxotere, and Cyclophosphamide (ATC) in Breast Cancer Patients With Positive Axillary Lymph Nodes

NCT00003782 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00003782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Three-Arm Randomized Trial to Compare Adjuvant Adriamycin and Cyclophosphamide Followed by Taxotere (AC-T); Adriamycin and Taxotere (AT); and Adriamycin, Taxotere, and Cyclophosphamide (ATC) in Breast Cancer Patients With Positive Axillary Lymph Nodes
Lead sponsor
NSABP Foundation Inc
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1999
Completion date
December 31, 2012
Enrollment
5,351 (actual)
Sites
157

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer